Business
BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Veritor™ System for SARS-CoV-2, a digital test designed to detect COVID-19 antigens in symptomatic individuals in about 15 minutes at doctors' offices, urgent care centers, retail clinics and other convenient points of care.
About this update from Becton, Dickinson And Company
[{"type":"text","content":"New CLIA-Waived Test Delivers Digital Results to Support Timely Clinical Decision-Making","length":93,"tagName":"p","attribs":{}},{"type":"text","content":"FRANKLIN LAKES, N.J., July 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Veritor™ System for SARS-CoV-2, a digital test designed to detect COVID-19 antigens in symptomatic individuals in about 15 minutes at doctors' offices, urgent care centers, retail clinics and other convenient points of care.","length":473,"tagName":"p"},{"type":"image","alt":"BD announced it has received FDA 510(k) clearance for the BD Veritor™ System for SARS-CoV-2, a digital test designed to detect COVID-19 antigens in symptomatic individuals in about 15 minutes at doctors’ offices, urgent care centers, retail clinics and other convenient points of care.","displaySize":"","headline":null,"caption":"BD announced it has received FDA 510(k) clearance for the BD Veritor™ System for SARS-CoV-2, a digital test designed to detect COVID-19 antigens in symptomatic individuals in about 15 minutes at doctors’ offices, urgent care centers, retail clinics and other convenient points of care.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":220,"url":"https://media.zenfs.com/en/prnewswire.com/9d2e45724ebce04b4113f9c2a6744ad0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/bDZY5HZpT1AvF5MQGxH9SA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM4ODtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/9d2e45724ebce04b4113f9c2a6744ad0","width":400,"height":220}},"href":"https://mma.prnewswire.com/media/2740777/BD___Veritor_System_for_SARS_CoV_2.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The BD Veritor™ System for SARS-CoV-2 has been available under Emergency Use Authorization (EUA) from the FDA since September 2020. The new 510(k) clearance will eventually replace the current EUA version of the test, starting in early fall 2025.","length":251,"tagName":"p"},{"type":"text","content":""This FDA clearance is part of our ongoing commitment to support health care providers with reliable, rapid diagnostic tools," said Nikos Pavlidis, worldwide president of BD D...